Cyclacel Pharmaceuticals
-$0.09 (-1.69%) As of 2:17 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCC and other ETFs, options, and stocks.
About CYCC
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases.
CEO
Spiro Rombotis
Employees
—
Headquarters
Berkeley Heights, New Jersey
Founded
1996
CYCC Key Statistics
Market Cap
60.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
95.29K
High Today
$5.29
Low Today
$5.19
Open Price
$5.26
Volume
16.87K
52 Week High
$11.42
52 Week Low
$3.12
CYCC Earnings
-$2.90
-$1.93
-$0.97
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours